Lara Zuberi, M.B.B.S. (M.D.)

Assistant Professor
Department of Medicine
Division of Hematology and Medical Oncology

Specializes in Hematology and Medical Oncology

Specialty

<a href = 'https://ufhealthjax.org/hematology-medical-oncology/' target = '_blank'>Hematology and Medical Oncology</a>

Professional Education

Medical Education: Aga Khan University, Karachi, Pakistan
Residency: Internal Medicine, Henry Ford Hospital, Detroit, MI, USA
Fellowship: Hematology and Medical Oncology, Henry Ford Hospital, Detroit, MI, USA

Publications

Search for publications by Lara Zuberi

Please note: The resulting entries may not reflect a complete or accurate listing for Lara Zuberi. Many journals are not indexed by PubMed, and there may be articles by other authors of the same name listed by this search.

30.346310 -81.662032 UF Health Hematology and Oncology – Jacksonville
3rd Floor, Faculty Clinic
653 West 8th Street
Jacksonville, FL 32209

Appointment: (904) 383-1021
Referral: (904) 244-1096
Referral Fax: (904) 244-1067

30.347300 -81.661650 UF Health Infusion Center – Jacksonville
4th Floor, Pavilion
555 West 8th Street
Jacksonville, FL 32209

Appointment: (904) 244-1560

Academic Office

4th Floor, Pavilion North
555 West 8th Street
Jacksonville, FL 32209
(904) 244-1680
lara.zuberi@jax.ufl.edu

Administrative Assistant
Quintyria Waters
(904) 244-1680
Quintyria.Waters@jax.ufl.edu

POLARIS: Palbociclib in Hormone Receptor Positive Advanced Breast Cancer: A Prospective Multicenter Non-Interventional Study

Purpose: The main goal of this study is to describe and analyze the prescribing and treatment patterns of palbociclib in routine clinical practice. The study will collect and assess information related to how you are treated by your doctor and also it will collect information about your experience. Clinical outcomes will also be assessed.
Protocol : AZA-MDS-006 Connect MDS and AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry

Purpose: This study is observational. An observational disease registry study means that only information about your disease and medical treatment that your study doctor is already prescribing as part of your standard medical care is collected. Standard medical care is the treatment normally given for a certain condition or illness.
Protocol: DLS CA 2016 The Collection of Whole Blood and Other Human Bio-Fluid from Subjects Clinically Diagnosed with Cancer and/ or Other Related Diseases

QUICK LINKS

MAIN MENU

CONNECT WITH US

University of Florida

College of Medicine – Jacksonville

UNIVERSITY of FLORIDA

Continuing Medical Education

Faculty Development

Simulation Education

Education Programs at UF Health

Clinical Trials

Additional Resources

Office of the Dean

Development & Alumni Affairs

Lara Zuberi, M.B.B.S. (M.D.)